Department of Neuroscience, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Glia. 2011 Jan;59(1):108-18. doi: 10.1002/glia.21080.
CXC chemokine receptor CXCR4 is expressed in vitro in both human and rodent adult neural progenitor cells (NPCs). It has been suggested that the CXCL12-CXCR4 axis potentially enhances the proliferation of NPCs. However, whether CXCR4 is expressed in the neural stem cells (NSCs), a subset of self-renewing and multipotent NPCs, and whether CXCR4 signaling is directly required for their proliferation are not clear. In this study, we report that CXCR4 is expressed in a subpopulation of NPCs in the early embryonic ventricular zone. In studies of a CXCR4(eGFP) bacterial artificial chromosomal (BAC) transgenic mouse line, we further isolated NPCs from E12.5 transgenic telencephalon and GFP(+) cells demonstrated self-renewal and multipotency in neurosphere assays in vitro. Consistent with these observations, we enriched GFP(+)/CXCR4(+) cells by fluorescence activated cell sorting (FACS) with either CXCR4 antibody 12G5 or GFP. Furthermore, we observed that CXCL12 alone did not activate the self-renewal of NPCs or increase the proliferation of NPCs that are induced by bFGF/EGF. However, we found that blocking CXCR4 receptor with antagonist AMD3100 impaired the bFGF/EGF-induced expansion of GFP(+) NPCs through modulating their cell cycling. In addition, AMD3100 treatment of pregnant mice reduced the generation of neurospheres from E12.5 embryos. Our data suggest that CXCR4 is a potential cell surface marker for early embryonic NSCs and modulates growth-factor signaling.
CXC 趋化因子受体 CXCR4 在体外表达于人和啮齿动物成年神经祖细胞 (NPCs)。有人提出,CXCL12-CXCR4 轴可能增强 NPC 的增殖。然而,CXCR4 是否表达于神经干细胞 (NSCs),即 NPC 的一个自我更新和多能亚群,以及 CXCR4 信号是否直接需要其增殖尚不清楚。在这项研究中,我们报告 CXCR4 表达于早期胚胎脑室区的 NPC 亚群中。在研究 CXCR4(eGFP)细菌人工染色体 (BAC) 转基因小鼠系时,我们进一步从小鼠 E12.5 端脑分离 NPC,并在体外神经球实验中鉴定 GFP(+)细胞具有自我更新和多能性。与这些观察结果一致,我们通过荧光激活细胞分选 (FACS) 用 CXCR4 抗体 12G5 或 GFP 对 GFP(+) / CXCR4(+) 细胞进行了富集。此外,我们观察到 CXCL12 本身不能激活 NPC 的自我更新,也不能增加 bFGF/EGF 诱导的 NPC 增殖。然而,我们发现用拮抗剂 AMD3100 阻断 CXCR4 受体可通过调节其细胞周期来损害 bFGF/EGF 诱导的 GFP(+) NPC 的扩增。此外,AMD3100 处理妊娠小鼠可减少来自 E12.5 胚胎的神经球生成。我们的数据表明,CXCR4 是早期胚胎 NSCs 的潜在细胞表面标志物,并调节生长因子信号。